| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIXT | Common | Award | $54,672 | +227,800 | +2.5% | $0.2400 | 9,427,800 | 15 Jan 2021 | Direct | |
| transaction | BIXT | Common | Award | $213,627 | +1,643,285 | +17% | $0.1300 | 11,071,085 | 04 Jun 2021 | Direct | |
| transaction | BIXT | Common | Gift | $267,565 | -1,871,085 | -17% | $0.1430 | 9,200,000 | 19 Nov 2021 | Direct | F1 |
| transaction | BIXT | Common | Gift | $192,800 | -400,000 | -4.3% | $0.4820 | 8,800,000 | 19 Nov 2021 | By Resources Unlimited LLC | |
| transaction | BIXT | Common | Award | $1,199 | +599,517 | $0.002000* | 559,517 | 03 Dec 2021 | By NDPD Pharma, Inc. |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BIXT | Warrants | Award | $18,000 | +50,000 | $0.3600 | 50,000 | 02 May 2021 | Common | 50,000 | $2.00 | by NDPD Pharma, Inc. | F2 |
| Id | Content |
|---|---|
| F1 | Shares returned to Company's treasury |
| F2 | The warrant agreement includes provisions for dilutive issuance and cash-less exercise |